Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
enGene Holdings Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 153K | Nov 30, 2023 | Direct | ||
Rain Oncology Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 110K | Feb 15, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ENGN | enGene Holdings Inc. | Nov 30, 2023 | 1 | $0 | 4 | Dec 4, 2023 | Chief Medical Officer |
ENGN | enGene Holdings Inc. | Oct 31, 2023 | 0 | $0 | 3 | Oct 31, 2023 | Chief Medical Officer |
RAIN | Rain Oncology Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chief Medical Officer |
RAIN | Rain Therapeutics Inc. | Jan 7, 2022 | 1 | $0 | 4 | Feb 4, 2022 | Chief Medical Officer |